American Healthcare REIT (NYSE:AHR) Posts Earnings Results, Beats Estimates By $0.02 EPS

by · The Markets Daily

American Healthcare REIT (NYSE:AHR – Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.02, Zacks reports. American Healthcare REIT had a negative net margin of 1.56% and a negative return on equity of 1.43%. The firm had revenue of $572.94 million for the quarter, compared to analyst estimates of $552.76 million. During the same quarter in the prior year, the firm earned $0.36 EPS. The company’s revenue was up 9.4% on a year-over-year basis. American Healthcare REIT updated its FY 2025 guidance to 1.690-1.72 EPS.

American Healthcare REIT Trading Up 1.7%

Shares of AHR stock traded up $0.78 on Thursday, reaching $47.87. The company had a trading volume of 2,406,401 shares, compared to its average volume of 1,368,584. The company has a 50-day moving average of $42.83 and a 200-day moving average of $38.64. American Healthcare REIT has a 12 month low of $25.25 and a 12 month high of $48.21. The stock has a market cap of $8.07 billion, a PE ratio of 30.19, a PEG ratio of 2.35 and a beta of 0.98. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.41.

American Healthcare REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 17th. Stockholders of record on Tuesday, September 30th were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.1%. American Healthcare REIT’s dividend payout ratio is -454.55%.

Insider Transactions at American Healthcare REIT

In other American Healthcare REIT news, EVP Mark E. Foster sold 3,850 shares of the stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $41.89, for a total value of $161,276.50. Following the sale, the executive vice president directly owned 59,100 shares in the company, valued at approximately $2,475,699. This trade represents a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.92% of the company’s stock.

Institutional Trading of American Healthcare REIT

Several hedge funds have recently added to or reduced their stakes in AHR. AQR Capital Management LLC grew its stake in American Healthcare REIT by 170.1% in the first quarter. AQR Capital Management LLC now owns 25,275 shares of the company’s stock valued at $766,000 after acquiring an additional 15,918 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of American Healthcare REIT by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 90,521 shares of the company’s stock valued at $2,743,000 after purchasing an additional 3,954 shares in the last quarter. NewEdge Advisors LLC grew its position in shares of American Healthcare REIT by 9.4% in the 1st quarter. NewEdge Advisors LLC now owns 23,509 shares of the company’s stock valued at $712,000 after purchasing an additional 2,011 shares during the period. Focus Partners Wealth increased its stake in American Healthcare REIT by 6.6% during the 1st quarter. Focus Partners Wealth now owns 25,809 shares of the company’s stock worth $782,000 after purchasing an additional 1,591 shares in the last quarter. Finally, Acadian Asset Management LLC acquired a new stake in American Healthcare REIT during the 1st quarter worth approximately $185,000. Institutional investors and hedge funds own 16.68% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently commented on AHR. Weiss Ratings reissued a “hold (c)” rating on shares of American Healthcare REIT in a research note on Wednesday, October 8th. JMP Securities lifted their target price on American Healthcare REIT from $45.00 to $50.00 and gave the company a “market outperform” rating in a research note on Friday, October 17th. Scotiabank reaffirmed an “outperform” rating on shares of American Healthcare REIT in a research note on Thursday, August 28th. Morgan Stanley reiterated an “overweight” rating on shares of American Healthcare REIT in a report on Wednesday, September 3rd. Finally, UBS Group initiated coverage on American Healthcare REIT in a report on Friday, September 19th. They set a “buy” rating and a $51.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $45.00.

Check Out Our Latest Research Report on American Healthcare REIT

About American Healthcare REIT

(Get Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

See Also